Target intelligence / Profile preview

AMP-activated protein kinase catalytic subunit alpha (AMPK-α) (AMPK-α)

Target
AMPK-α
Molecular classification
Enzyme, Serine/threonine-protein kinase, Kinase, Metabolic sensor
01

Overview

AMP-activated protein kinase catalytic subunit alpha (AMPK-α) is the enzymatic component of the heterotrimeric AMPK complex, which serves as a master regulator of cellular and whole-body energy homeostasis [1, 6]. It functions as a metabolic sensor that is activated in response to energy stress, characterized by an increase in the AMP/ATP or ADP/ATP ratio [4, 10]. Once activated, AMPK-α phosphorylates a wide array of downstream targets to inhibit energy-consuming anabolic processes, such as lipid and protein synthesis, while stimulating energy-producing catabolic pathways like fatty acid oxidation and glucose uptake [8, 14]. This makes it a primary therapeutic target for metabolic disorders, including type 2 diabetes and obesity, where it helps restore insulin sensitivity and glucose balance [3, 12]. Beyond its metabolic roles, AMPK-α is involved in regulating autophagy, cell growth through the inhibition of the mTORC1 pathway, and inflammatory responses [1, 15]. Pharmacological modulation includes indirect activators like metformin and direct small-molecule activators such as MK-8722 [14, 15]. However, therapeutic development faces challenges such as potential cardiac hypertrophy and the complex, context-dependent role of AMPK in cancer progression [15].

Other names
PRKAA1PRKAA25'-AMP-activated protein kinase catalytic subunit alpha-15'-AMP-activated protein kinase catalytic subunit alpha-2ACACA kinaseHMGCR kinaseTau-protein kinase PRKAA1
02

Mechanism of action

Activation of the catalytic subunit through allosteric binding of AMP/ADP or direct small-molecule activators, leading to phosphorylation of downstream metabolic and growth-regulating substrates.

03

Biological functions

Energy homeostasisMetabolism regulationAutophagyCell growth regulationMitochondrial biogenesisSignal transductionCell cycle regulation
04

Disease associations

Type 2 diabetesObesityCancerCardiovascular diseaseNon-alcoholic fatty liver disease (NAFLD)Neurodegenerative diseaseInflammation
05

Safety considerations

Cardiac hypertrophyIncreased appetiteDual role in cancer (tumor suppression vs. survival support)Off-target metabolic effects
06

Interacting drugs

Metformin

7 more in the full profile.

07

Biomarkers

Phospho-AMPK (Thr172)Phospho-Acetyl-CoA Carboxylase (p-ACC)PGC-1α expressionGLUT4 translocation

Beyond the preview

Go deeper on AMP-activated protein kinase catalytic subunit alpha (AMPK-α) (AMPK-α).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMP-activated protein kinase catalytic subunit alpha (AMPK-α) (AMPK-α).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call